Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

July 2025

Study Validates Techcyte Fusion™ AI-Assisted Kidney Biopsy Evaluation to Improve Organ Allocation Efficiency

2025-09-16T10:24:17+00:00

Techcyte is proud to share results from a published pilot study demonstrating the effectiveness of its AI-powered kidney biopsy algorithm, part of the Techcyte Fusion™ Organ Donation Suite, in improving the speed, accuracy, and consistency of donor organ evaluations. The study titled “Enhancing Organ Allocation Efficiency: A Pilot Study Evaluating Artificial Intelligence-Assisted Assessment of Donor Kidney  [...]

Study Validates Techcyte Fusion™ AI-Assisted Kidney Biopsy Evaluation to Improve Organ Allocation Efficiency2025-09-16T10:24:17+00:00

The Versailles Hospital Center Chooses Tribun Health for Its Transition to Digital Pathology

2025-07-10T12:00:39+00:00

A Major Step Toward Precision Diagnostics with the Implementation of CaloPix® Tribun Health, European leader in AI-enhanced digital pathology, is proud to announce that the Versailles Hospital Center, the supporting institution of GHT 78 Sud, has selected its imaging platform, CaloPix®, to support the digital transformation of its pathology department. This decision represents a strategic [...]

The Versailles Hospital Center Chooses Tribun Health for Its Transition to Digital Pathology2025-07-10T12:00:39+00:00

Democratizing Cancer Diagnostics: Low-Cost Digital Pathology Rivals High-End Systems

2025-07-07T10:50:27+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a recent study, researchers at the University of Chicago and the University of Chicago Medical Center developed a low-cost, open-source digital pathology workstation that performs on par with expensive clinical-grade systems in cancer diagnostics.1 This $230 device, coupled with artificial intelligence, could increase access [...]

Democratizing Cancer Diagnostics: Low-Cost Digital Pathology Rivals High-End Systems2025-07-07T10:50:27+00:00

elea Co-Founder Featured on the Podcast “Patho aufs Ohr”

2025-07-07T10:04:18+00:00

In the latest episode of “Patho auf’s Ohr”, elea's Co-Founder & CMO Dr. Sebastian Casu shares his perspective on the future of pathology - and explains why artificial intelligence in digital pathology isn’t just a trend, but a true turning point. Key topics include: The vision behind elea, elea's AI-powered Pathology Operating System, How technology, humanity, [...]

elea Co-Founder Featured on the Podcast “Patho aufs Ohr”2025-07-07T10:04:18+00:00

Owkin and Newcastle upon Tyne Hospitals NHS Foundation Trust Announce Five-year AI Partnership to Accelerate Medical Discovery

2025-11-04T13:58:12+00:00

Owkin, a leading agentic AI company, and Newcastle upon Tyne Hospitals NHS Foundation Trust, one of the largest NHS trusts in the UK, have entered a five-year partnership to explore how agentic AI can help accelerate breakthroughs and advance drug discovery, development, and diagnostics. To kick off the partnership, Newcastle is supporting a new project to [...]

Owkin and Newcastle upon Tyne Hospitals NHS Foundation Trust Announce Five-year AI Partnership to Accelerate Medical Discovery2025-11-04T13:58:12+00:00

Digital Pathology at Clínica Universidad de Navarra: Accelerating Diagnostics with MDPC‑8127

2026-03-17T22:07:01+00:00

Clínica Universidad de Navarra (CUN), a leading university hospital with campuses in Pamplona and Madrid, transitioned to digital pathology in 2020 to enhance diagnostic accuracy and workflow efficiency. With a strong focus on oncological pathology, the multidisciplinary team required a visualization solution capable of supporting complex histological assessments, remote collaboration, and future AI integration. As an [...]

Digital Pathology at Clínica Universidad de Navarra: Accelerating Diagnostics with MDPC‑81272026-03-17T22:07:01+00:00

Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellison

2025-07-10T08:16:12+00:00

Imagene delivers a living intelligence engine for adaptive, insight-driven precision medicine. Imagene AI, a pioneer in multi‑modal foundation models for precision medicine, today announced the successful close of a $23 million Series B financing round led by Oracle Chairman and CTO Larry Ellison. This latest infusion brings Imagene AI’s total capital raised to $45 million [...]

Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellison2025-07-10T08:16:12+00:00

elea at the 108th Annual Meeting of the German Society of Pathology: a Resounding Success

2025-07-09T15:11:23+00:00

The 108th Annual Meeting of the German Society of Pathology was a clear success for elea - marked by vibrant discussions, outstanding interest, and a shared vision for the digital future of pathology. Throughout the congress, the elea booth remained a central point of contact. Numerous visitors engaged with the team to learn more about elea’s [...]

elea at the 108th Annual Meeting of the German Society of Pathology: a Resounding Success2025-07-09T15:11:23+00:00

Case of the Month | July 2025 | Evaluating a Prostatic Abnormality in a Cocker Spaniel

2025-07-16T10:02:39+00:00

Author: Alina Bodnariu DVM MSc PhD FRCPath MRCVS Case presentation A 10-year-old Cocker Spaniel presented with a history of intermittent haematuria of five days duration. Rectal examination revealed an irregular, painful prostate gland. Ultrasound examination revealed a cystic and fibrotic prostate gland. A prostatic wash was performed, and the sample was submitted to NationWide Laboratories [...]

Case of the Month | July 2025 | Evaluating a Prostatic Abnormality in a Cocker Spaniel2025-07-16T10:02:39+00:00

June 2025

PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis

2025-07-09T10:33:14+00:00

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings. Building on the initial 510(k) clearance for AISight Dx(Novo) in 2022, this latest milestone underscores the platform’s [...]

PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis2025-07-09T10:33:14+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top